Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Cerebral Cortex (New York, N.Y. : 1991)|July 11, 2003
In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferentsM Victoria Puig, Pau Celada, Llorenç Díaz-Mataix, et al.
Neuropharmacology|December 10, 2017
The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptorsMaurizio S Riga, Laia Lladó-Pelfort, Francesc Artigas, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 18, 2022
Preferential In Vivo Inhibitory Action of Serotonin in Rat Infralimbic versus Prelimbic Cortex: Relevance for Antidepressant TreatmentsElena López-Terrones, Pau Celada, Maurizio S Riga, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 7, 2011
5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneuronsLaia Lladó-Pelfort, Noemí Santana, Valentina Ghisi, et al.
Biological Psychiatry|January 22, 2011
Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapineNoemí Santana, Eva Troyano-Rodriguez, Guadalupe Mengod, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 29, 2004
In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptorsM Victoria Puig, Noemí Santana, Pau Celada, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 13, 2017
The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networksHanna E van den Munkhof, Jørn Arnt, Pau Celada, et al.
The International Journal of Neuropsychopharmacology|March 22, 2014
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugsMaurizio S Riga, Guadalupe Soria, Raúl Tudela, et al.
Neuropharmacology|October 20, 2015
The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptorsMaurizio S Riga, Analia Bortolozzi, Letizia Campa, et al.
European Journal of Pharmacology|June 9, 2023
Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine DMaurizio S Riga, Veronica Paz, Michael Didriksen, et al.
Pageof 12